Boston Scientific · 1 month ago
Senior Director, Financial Processes and Systems
Boston Scientific is at a pivotal moment in our global technology transformation journey, and they are seeking a Senior Director, Financial Processes and Systems to lead the implementation of finance systems. This role will oversee a suite of financial systems, collaborate with senior stakeholders, and drive initiatives in process automation and data governance.
Health CareMedicalMedical Device
Responsibilities
Develop and implement a systems strategy to support Boston Scientific’s objective of a best-in-class, agile finance organization
Collaborate with IT Finance to deliver system launches, including Magellan, EPM/PPM, and workforce planning
Establish processes to stabilize and enhance financial applications post-launch
Lead and mentor a team of ten professionals
Oversee systems supporting financial close, consolidation, planning, and forecasting
Manage master data governance for all finance data elements, including design and execution of definitions, rules, and hierarchies
Support business growth through effective partnership on acquisitions, divestitures, and new entity setup
Drive process improvements and automation to enhance user experience and adapt to evolving business needs
Develop and maintain training strategies aligned with system changes
Engage with external consultants to ensure timely, high-quality project delivery
Qualification
Required
Bachelor's degree in Accounting, Finance, or Business Administration
Extensive experience with system implementations (Magellan/SAP, EPM/PPM)
Minimum of 10 years' experience in progressive financial management and leadership roles
Proven ability to lead projects, launch systems, and develop high-performing teams
Strong stakeholder management and communication skills, with executive presence
Results-driven, with excellent organizational and time management abilities
Company
Boston Scientific
Boston Scientific is a medical technology company that designs and develops medical devices to diagnose and treat a wide range of condition.
Funding
Current Stage
Public CompanyTotal Funding
$10.02B2025-02-21Post Ipo Debt· $1.58B
2024-02-22Post Ipo Debt· $2.17B
2022-03-04Post Ipo Debt· $3.28B
Recent News
2026-01-13
2026-01-13
2026-01-13
Company data provided by crunchbase